Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
出版年份 2021 全文链接
标题
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
作者
关键词
COVID-19, Cancer, SARS-CoV-2, Vaccine, Vaccination, Third dose, Booster dose, Humoral response, Monitoring, Anti-Spike antibodies
出版物
EUROPEAN JOURNAL OF CANCER
Volume 162, Issue -, Pages 182-193
出版商
Elsevier BV
发表日期
2021-12-16
DOI
10.1016/j.ejca.2021.12.011
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
- (2021) M.C. Garassino et al. ANNALS OF ONCOLOGY
- Current Perspectives: SARS-CoV-2 vaccines for cancer patients: a call to action
- (2021) Chiara Corti et al. EUROPEAN JOURNAL OF CANCER
- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
- (2021) Rémy Duléry et al. AMERICAN JOURNAL OF HEMATOLOGY
- Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose
- (2021) Evangelos Terpos et al. BLOOD
- WHO International Standard for anti-SARS-CoV-2 immunoglobulin
- (2021) Paul A Kristiansen et al. LANCET
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Delayed production of neutralizing antibodies correlates with fatal COVID-19
- (2021) Carolina Lucas et al. NATURE MEDICINE
- Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
- (2021) Václav Šimánek et al. Diagnostics
- Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
- (2021) P. Grivas et al. ANNALS OF ONCOLOGY
- Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
- (2021) P. Heudel et al. ANNALS OF ONCOLOGY
- Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
- (2021) Paola Ghione et al. BLOOD
- Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
- (2021) Alfredo Addeo et al. CANCER CELL
- Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
- (2021) Laura Mansi et al. EUROPEAN JOURNAL OF CANCER
- Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
- (2021) Jérôme Barrière et al. EUROPEAN JOURNAL OF CANCER
- COVID-19 vaccines in adult cancer patients with solid tumors undergoing active treatment: seropositivity and safety. A prospective observational study in Italy
- (2021) Luigi Cavanna et al. EUROPEAN JOURNAL OF CANCER
- High levels of anti–SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine
- (2021) Dominic Fong et al. EUROPEAN JOURNAL OF CANCER
- Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection
- (2021) Thomas Perkmann et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
- (2021) Ilaria Vicenti et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- A French cohort for assessing COVID-19 vaccine responses in specific populations
- (2021) Paul Loubet et al. NATURE MEDICINE
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
- (2021) Jocelyn Keehner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
- (2021) Amarendra Pegu et al. SCIENCE
- BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers
- (2021) Yaniv Lustig et al. Lancet Respiratory Medicine
- Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
- (2021) Floriane Gallais et al. EBioMedicine
- Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
- (2021) Thomas Perkmann et al. Microbiology Spectrum
- Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
- (2021) Yoonjoo Kim et al. Diagnostics
- Severe COVID-19 in patients with hematological cancers presenting with viremia
- (2021) J.M. Michot et al. ANNALS OF ONCOLOGY
- High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment
- (2021) Tania Buttiron Webber et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
- (2021) Son Tran et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
- (2021) Einat S. Shmueli et al. EUROPEAN JOURNAL OF CANCER
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
- (2021) Rabah Redjoul et al. Lancet Haematology
- Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19)
- (2020) Astrid Lièvre et al. EUROPEAN JOURNAL OF CANCER
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
- (2020) Antoni Ribas et al. Cancer Discovery
- Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection
- (2020) QuanQiu Wang et al. JAMA Oncology
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
- (2011) Jens Wrammert et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started